Last Week’s Hot Topic on Cystic Fibrosis

admin avatar

by admin |

Share this article:

Share article via email

news_9-21

Last week’s hot topic on Cystic Fibrosis titled Phase 3 Trial of Inhaled Antibiotic to Treat CF-related Lung Infections Supported by $20M in New Financing was written by Daniela Semedo.

The article is focused on Savara Pharmaceuticals recently announcing that it has closed a $20 million Series C financing round, which will be used to advance a pivotal Phase 3 clinical trial of AeroVanc (vancomycin hydrochloride inhalation powder), the first dry powder inhaled antibiotic being developed for the treatment of methicillin-resistant staphylococcus aureus (MRSA) lung infection in cystic fibrosis (CF) patients.

Read more articles about cystic fibrosis here: http://bit.ly/1jNDqsz


Featured Column

How to Ask for and Offer Help

A banner for Kate Delany's "Breathe and Believe" column that depicts a pair of lungs with flowers blossoming from them.
In times of need, we may not know how to ask for help or offer it to others. Columnist Kate Delany shares helpful tips on how to do it.

Read the Column


Your CF Community


Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.